U.S. Markets closed

Pacira Pharmaceuticals, Inc. (PCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
35.70-0.60 (-1.65%)
At close: 4:00PM EDT

35.70 0.00 (0.00%)
After hours: 4:45PM EDT

People also watch
SUPNIRWDPTLACLVSPTCT
  • M
    Mel
    Mel

    MICROCAP SPECIAL ALERT – BioLargo’s (BLGO) Surprise Acquisition of ENTIRE World Class Engineering Team from Fortune 500 CB&I Environmental & Infrastructure, Inc. Combined with New Financing Signals STRONG BUY as AOS Disruptive Water Treatment System Now Ready for $860 Billion Market

    BLGO COMMERCIAL REVENUES ARE STARTING NOW AND STRONGLY POSITIONED TO EXPLODE FOR YEARS TO COME

    Follow this chain of facts to understand the powerful investment implications:

    1. BLGO developed and owns the breakthrough AOS Water Treatment system that was just unveiled at the University of Alberta. The AOS is validated by many leading experts as the biggest breakthrough in water treatment in history

    2. The AOS system was validated by 1,600 studies and by the world’s largest water engineering company to disinfect and to also remove toxic contaminants better, faster and cheaper than all technologies

    3. Over 35 government grants support the AOS system

    4. After 10 years of development, the AOS system is now commercially ready for engineering to tailor and build it for user’s specific needs

    5. BLGO just acquired THE ENTIRE ENGINEERING INNOVATION TEAM THAT CREATED GIANT REVENUES FOR CB&I and now creates instant big revenues for BLGO

    6. The new engineering team brings substantial new business on day 1

    7. BLGO’S new Engineering and Science Division has powerful established business relationships with giant users for the AOS

    8. BLGO’s new Engineering & Science Division from CB&I is strongly incentivized to generate big and profitable revenues

    9. BLGO hired Dr Shan Yong as head of BD for the AOS. Dr Yong has long established relationships with Veolia and the world’s largest water companies

    10. BLGO just closed a finance commitment for $10 million with Lincoln Park Capital

    11. BLGO Clyra Medical division within days of filing 510k for novel low cost, best in class wound care products in a $10 billion market

    12. Clyra wound care products kill even resistant microbials (ESKAPE PATHOGENS) and promote healing

    13. 510k is a 90-day process

    14. Tanya Rhodes was head of wound care product development at giant Smith & Nephew

    15. Tanya Rhodes is now spearheading Clyra’s disruptive product entry into $10 billion market

    16. Several more proprietary blockbuster and disruptive wound care products are in pipeline

    17. CupriDyne industrial air treatment odor control is being sold now and is quickly being adopted by major companies

    18. 3 of the top 10 waste management companies have already signed National Purchasing Agreements and sales are increasing rapidly

    19. Word on the street is that CupiDyne is going to take over odor control

    20. CupriDyne sales potential is billions per year

    21. BLGO is destined to achieve enormous revenues and multi-billion dollar market cap in near term with major prolonged growth for years to come.

    https://finance.yahoo.com/news/biolargo-acquires-world-class-engineering-133000876.html

    BioLargo Acquires World-Class Engineering Team to Form a New Engineering Services Subsidiary and Enters into Common Stock Purchase Agreement for Up to $10 Million with Lincoln Park Capital
    Westminster, CA, Sept. 11, 2017-- BioLargo, Inc., a sustainable science and technology company that delivers practical solutions for clean water, clean air and advanced wound care, announced today it finalized ...
    finance.yahoo.com
  • g
    grntip
    grntip
    Are you guys worried about Heron Therapeutics HTX-011 coming to market next few quarters? Your Exparel does what the HTX-011 does only not nearly as good as far as my research shows. Plenty of info on both drugs from trials and on going trials out there. I am buying Herons stock, HRTX. Not knocking your product but just I am just hoping HRTX gets up over $100 a share like you guys once had when Exparel first came out. Read up on HTX-011. It may be time to switch ponys and save yourselfs a bunch more worries. Not being a basher or jerk, just looking at the facts as I read them. Good Luck
  • 咩咩的客
    咩咩的客
    It seems the CEO trying hard to paint a brighter future; however, it sounds very far away and not on a firm footing. I hope it's not just lip services all around, not yet to bet the money on this one yet. Just me 5 cents!
  • p
    pops or homo
    pops or homo
    BS..on trial saying didn't work for knee...Personally had it during 2 back surgeries...after surgery I was on morphine drip..I pulled the Iv..didn't need it...Great drug...someone's lying and manipulating stock price.
  • L
    Long Term
    Long Term
    No wonder the old CEO was let go - how do mess up a multi year trial?
  • j
    jack
    jack
    Good result and shares down?
  • T
    TCT
    TCT
    dirty hospital secret: exparel costs $300/vial but hospitals charge the patient $1200-1500 while complaining that the drug costs too much.
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    PCRX is up 5.44% to 45.95
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    PCRX is up 5.20% to 44.50
  • Y
    Yahoo Finance Insights
    Yahoo Finance Insights
    PCRX is down -5.06% to 42.25
  • m
    michael
    michael
    trump appoints governor Cooper NC to opioid abuse panel. NC receives 30 million grant to fight abuse good place to start is hospital's and dentists. Go Exparel! !!!!!
  • A
    Anonymous
    Anonymous

    Received an alert this am about $PCRX from http://yugestocks.com/?s=PCRX, you may want to take a look. The designs are well within available limits.(we just made it Making money trading stocks.

    Yuge Stocks: Trading Stocks and Making Money
    Stock alerts from the Yuge Stocks. Stock trading, making money and always looking for the next big money maker.
    yugestocks.com
  • s
    selnhms
    selnhms
    $KERX conversation
    From dough on Twitter.
    COWEN Names with the best potential to report Q1 results in excess of consensus include $ALXN $CELG $EXEL $ICPT $IRWD $KERX $PCRX $VRTX
  • A
    Anonymous
    Anonymous

    He who spares the rod hates his son, but he who loves him is careful to discipline him. http://dataunion.tistory.com/2860

    Pacira Pharmaceuticals Inc NASDAQ : PCRX Correlation Histogram
    X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 2,830 NASDAQ Stocks Price Analysis This stock mode of correlation coefficient is 0.7 In other words, the correlation coefficient of the other stock
    dataunion.tistory.com
  • L
    Laurie
    Laurie
    PCRX appears to suggest upside opportunity given the analyst mean target price at 58.83. have you guys heard of aawesomestocks. i started receiving their allerts and so far i am happy.
  • M
    Mousheg
    Mousheg
    just shorted
  • p
    pops or homo
    pops or homo
    told you so
  • A
    Anonymous
    Anonymous
    PCRX has just seen the last of the selling. Looks like a potential push higher with a insider ownership of 0.20%. Im not sure about you guys but lionStackal/erts has provided me with some pretty good trade ideas. I messed up executing some of them but thats on me.
  • p
    pops or homo
    pops or homo
    exparell is the money maker...cost too much and hospitals don't want to pay the cost for the patient.. been on the med twice for surgery...drug is excellent and leaves patients in less pain after surgery...this company's stock should rocket to the moon
  • h
    heroninvestor
    heroninvestor
    NO substantive/consistent advantages to the use of EXPAREL over other local anesthetics when compared using the same method of analgesia